XML 63 R33.htm IDEA: XBRL DOCUMENT v3.20.1

WARRANTS (Tables) - Warrant [Member]

12 Months Ended

Nov. 30, 2019

Class of Warrant or Right [Line Items]

Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]

				Number of			Weighted- Average
				Warrants			Exercise
				Granted			Price
							$
Outstanding at November 30, 2017				20,941,160			0.18
Granted				5,100,000			0.25
Expired				—			—
Outstanding at November 30, 2018				26,041,160			0.19
Granted				22,223,058			0.25
Expired				(2,476,999	)		(0.16	)
Outstanding at November 30, 2019				45,787,219			0.22
Exercisable at November 30, 2019				45,037,219			0.22
Exercisable at November 30, 2018				26,041,160			0.19

Schedule of Stockholders' Equity Note, Warrants or Rights, Weighted Average Remaining Contractual Term, Outstanding [Table Text Block]

		2019			2018
		(Years)			(Years)
Total outstanding warrants		3.55			3.88
Total exercisable warrants		3.50			3.88

Warrants Granted, September 16, 2019 [Member]

Class of Warrant or Right [Line Items]

Schedule of Share-based Payment Award, Warrants, Valuation Assumptions [Table Text Block]

Risk free rate		1.69%
Expected dividends		0%
Expected volatility		150%
Expected life		4.35 years
Market price of the Company's common stock on date of grant	$	0.16
Exercise price	$	0.25

Warrants Granted, July 22, 2019 [Member]

Class of Warrant or Right [Line Items]

Schedule of Share-based Payment Award, Warrants, Valuation Assumptions [Table Text Block]

Risk free rate		1.8%
Expected dividends		0%
Expected volatility		154%
Expected life		4.5 years
Market price of the Company's common stock on date of grant	$	0.16
Exercise price	$	0.25

Warrants Granted, April 22, 2019 and May 20, 2019 [Member]

Class of Warrant or Right [Line Items]

Schedule of Share-based Payment Award, Warrants, Valuation Assumptions [Table Text Block]

Risk free rate		2.21—2.39%
Expected dividends		0%
Expected volatility		155—156%
Expected life		4.5 years
Market price of the Company's common stock on date of grant	$	0.15
Exercise price	$	0.25

Warrants Granted, October 22, 2018 [Member]

Class of Warrant or Right [Line Items]

Schedule of Share-based Payment Award, Warrants, Valuation Assumptions [Table Text Block]

Risk free rate		3.05%
Expected dividends		0%
Expected volatility		159%
Expected life		5 years
Market price of the Company's common stock on date of grant	$	0.14
Exercise price	$	0.25

X

- Definition

Schedule of Share-based Payment Award, Warrants, Valuation Assumptions

+ References

No definition available.

+ Details

Name:	byrn_ScheduleOfSharebasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock
Namespace Prefix:	byrn_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of Stockholders' Equity Note, Warrants or Rights,weighted average remaining contractual term, Outstanding.

+ References

No definition available.

+ Details

Name:	byrn_ScheduleOfStockholdersEquityNoteWarrantsOrRightsweightedAverageRemainingContractualTermOutstandingTableTextBlock
Namespace Prefix:	byrn_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=byrn_WarrantsGrantedOnSeptember162019Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=byrn_WarrantsGratedOnJuly222019Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=byrn_WarrantsGratedOnApril222019AndMay202019Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardDateAxis=byrn_WarrantsGratedOnOctober222018Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: